Zimmer Biomet Holdings (ZBH) Income from Non-Controlling Interests (2011 - 2026)
Zimmer Biomet Holdings' quarterly Income from Non-Controlling Interests came in at $200000.0 in Q1 2026, down 66.67% year-on-year from $600000.0 in Q1 2025, and up 113.33% quarter-over-quarter from -$1.5 million in Q4 2025.
Zimmer Biomet Holdings has reported Income from Non-Controlling Interests for 16 years, with the latest figure at $200000.0 in Q1 2026.
- For the quarter ending Q1 2026, Income from Non-Controlling Interests fell 66.67% year-over-year to $200000.0; the trailing twelve-month figure through Mar 2026 stood at -$400000.0 (down 122.22% YoY), and the FY2025 full-year result was -$100000.0, down 106.67% from the prior year.
- Income from Non-Controlling Interests for Q1 2026 stood at $200000.0, up from -$1.5 million in the prior quarter.
- The five-year high for Income from Non-Controlling Interests was $700000.0 in Q4 2024, with the low at -$1.5 million in Q4 2025.
- Average Income from Non-Controlling Interests over 5 years is $229411.8, with a median of $300000.0 recorded in 2022.
- Year-over-year, Income from Non-Controlling Interests jumped 200.0% in 2022 and tumbled 314.29% in 2025.
- Tracing ZBH's Income from Non-Controlling Interests over 5 years: stood at $300000.0 in 2022, then surged by 66.67% to $500000.0 in 2023, then soared by 40.0% to $700000.0 in 2024, then sank by 314.29% to -$1.5 million in 2025, then soared by 113.33% to $200000.0 in 2026.
- The last three Income from Non-Controlling Interests figures came in at $200000.0 (Q1 2026), -$1.5 million (Q4 2025), and $300000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 6.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -2.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -5.85 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 22.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 100,000.00 |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn | 200,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 200,000.00 |
| Dec 31, 2025 | -1.50 Mn |
| Sep 30, 2025 | 300,000.00 |
| Jun 30, 2025 | 600,000.00 |
| Mar 31, 2025 | 600,000.00 |
| Dec 31, 2024 | 700,000.00 |
| Sep 30, 2024 | 200,000.00 |
| Jun 30, 2024 | 300,000.00 |
| Mar 31, 2024 | 400,000.00 |
| Dec 31, 2023 | 500,000.00 |
| Sep 30, 2023 | 200,000.00 |
| Jun 30, 2023 | 200,000.00 |
| Mar 31, 2023 | 200,000.00 |
| Dec 31, 2022 | 300,000.00 |
| Sep 30, 2022 | 200,000.00 |
| Jun 30, 2022 | 300,000.00 |
| Mar 31, 2022 | 200,000.00 |
| Dec 31, 2021 | 100,000.00 |
| Sep 30, 2021 | 200,000.00 |
| Jun 30, 2021 | 600,000.00 |
| Mar 31, 2021 | -400,000.00 |
| Dec 31, 2020 | 100,000.00 |
| Sep 30, 2020 | 3.60 Mn |
| Jun 30, 2020 | -1.60 Mn |
| Mar 31, 2020 | -600,000.00 |
| Dec 31, 2019 | 700,000.00 |
| Sep 30, 2019 | 900,000.00 |
| Jun 30, 2019 | -1.80 Mn |
| Mar 31, 2019 | 100,000.00 |
| Dec 31, 2018 | -1.40 Mn |
| Sep 30, 2018 | -100,000.00 |
| Jun 30, 2018 | -100,000.00 |
| Mar 31, 2018 | 1.50 Mn |
| Dec 31, 2017 | -200,000.00 |
| Jun 30, 2017 | -100,000.00 |
| Mar 31, 2017 | -100,000.00 |
| Dec 31, 2016 | 100,000.00 |
| Sep 30, 2016 | -900,000.00 |
| Jun 30, 2016 | -400,000.00 |
| Mar 31, 2016 | -100,000.00 |
| Dec 31, 2015 | -300,000.00 |
| Jun 30, 2015 | -200,000.00 |
| Mar 31, 2015 | -300,000.00 |
| Dec 31, 2014 | -100,000.00 |
| Sep 30, 2014 | -200,000.00 |
| Jun 30, 2014 | -400,000.00 |
| Mar 31, 2014 | -400,000.00 |
| Dec 31, 2013 | -500,000.00 |
| Sep 30, 2013 | -300,000.00 |
| Jun 30, 2013 | -400,000.00 |
| Mar 31, 2013 | -600,000.00 |
| Dec 31, 2012 | -500,000.00 |
| Sep 30, 2012 | -400,000.00 |
| Jun 30, 2012 | -500,000.00 |
| Mar 31, 2012 | -700,000.00 |
| Dec 31, 2011 | -500,000.00 |
| Sep 30, 2011 | -300,000.00 |